Cargando…
Successful treatment of mycobacterial infection associated hemophagocytic lymphohistiocytosis with etoposide and anti-tuberculous therapy: a case report
BACKGROUND: Hemophagocytic lymphohistiocytosis (HLH) is a rare and potentially life-threatening disorder characterized by an exacerbated but ineffective inflammatory response, which can be classified as primary and secondary HLH. HLH associated with Mycobacterium tuberculosis is uncommon. This case...
Autores principales: | Wang, Yan-Hong, Ba, Jun-Hui, Shi, Xiao-Wei, Wu, Ben-Quan |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
BioMed Central
2020
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7201620/ https://www.ncbi.nlm.nih.gov/pubmed/32370734 http://dx.doi.org/10.1186/s12879-020-05016-4 |
Ejemplares similares
-
The role of etoposide in the treatment of adult patients with hemophagocytic lymphohistiocytosis
por: Zondag, Timo C. E., et al.
Publicado: (2023) -
Hemophagocytic lymphohistiocytosis complicating nontuberculous mycobacterial infection
por: Gupta, Stuti, et al.
Publicado: (2019) -
Possible role of low-dose etoposide therapy for hemophagocytic lymphohistiocytosis by COVID-19
por: Takami, Akiyoshi
Publicado: (2020) -
Etoposide in patients with rheuma-associated hemophagocytic lymphohistiocytosis / macrophage activation syndrome
por: Henter, Jan-Inge, et al.
Publicado: (2011) -
Requirement for etoposide in the treatment of pregnancy related hemophagocytic lymphohistiocytosis: a multicenter retrospective study
por: Song, Yue, et al.
Publicado: (2019)